MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Viatris UK Healthcare Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Zentiva Pharma UK Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (A A H Pharmaceuticals Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (Accord-UK Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (Crescent Pharma Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (Medihealth (Northern) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Use with caution

Zolmitriptan 2.5mg tablets (Pilsco Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

No Stability Information

Zolmitriptan 5mg orodispersible tablets sugar free (A A H Pharmaceuticals Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 5mg orodispersible tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zolmitriptan 5mg orodispersible tablets sugar free (Accord-UK Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 5mg orodispersible tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zolmitriptan 5mg orodispersible tablets sugar free (Alliance Healthcare (Distribution) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 5mg orodispersible tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zolmitriptan 5mg orodispersible tablets sugar free (Crescent Pharma Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 5mg orodispersible tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zolmitriptan 5mg orodispersible tablets sugar free (Genus Pharmaceuticals Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 5mg orodispersible tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zolmitriptan 5mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 5mg orodispersible tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.